Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial

Collapse authors list.
Kemp, GJ ORCID: 0000-0002-8324-9666, Charles-Edwards, G, Amaral, N, Sleigh, A, Ayis, S, Catibog, N, McDonagh, T, Monaghan, N, Amin-Youssef, G, Shah, AM et al (show 1 more authors) and Okonko, DO (2019) Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial. Circulation.

Text FERRIC-HF II Circulation 2019.pdf - Accepted Version Download (1MB)

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	01 Mar 2019 08:28
Last Modified:	06 Nov 2019 13:58
DOI:	10.1161/CIRCULATIONAHA.118.038516.
URI:	http://livrepository.liverpool.ac.uk/id/eprint/3033617

Available Versions of this Item

• Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial. (deposited 01 Mar 2019 08:28) [Currently Displayed]
  • Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency: FERRIC-HF II Randomized Mechanistic Trial. (deposited 06 Nov 2019 13:58)

Repository Staff Access